Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vitrafy Life Sciences Ltd. ( (AU:VFY) ) has issued an announcement.
Vitrafy Life Sciences Ltd. announced the quotation of 8,744,376 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of November 21, 2025. This move is expected to enhance the company’s market presence and provide additional capital for its growth initiatives, potentially impacting its operational capabilities and industry positioning positively.
The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.10 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.
More about Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Ltd. operates in the life sciences industry, focusing on innovative solutions and technologies to enhance healthcare outcomes. The company is engaged in the development and commercialization of advanced life science products, aiming to address critical needs in the healthcare sector.
Average Trading Volume: 26,392
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$93.86M
For an in-depth examination of VFY stock, go to TipRanks’ Overview page.